Depression of myosin B by catecholamine analogs: mechanism and in vivo significance.
D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000378:metabolism; D055598:Chemical Phenomena; D011232:Chemical Precipitation; D002621:Chemistry; D003900:Desoxycorticosterone / Q000494:pharmacology; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D005782:Gels; D007545:Isoproterenol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D008928:Mitochondria / Q000201:enzymology; D009124:Muscle Proteins / Q000378:metabolism*; D009206:Myocardium / Q000201:enzymology; D009210:Myofibrils / Q000201:enzymology; D010627:Phenethylamines / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology
D004983:Ethanolamines; D005782:Gels; D009124:Muscle Proteins; D010627:Phenethylamines; D013565:Sympatholytics; D010656:Phenylephrine; D003900:Desoxycorticosterone; D011433:Propranolol; D000251:Adenosine Triphosphatases; D008729:Methoxamine; D007545:Isoproterenol; D002118:Calcium; D004837:Epinephrine